» Articles » PMID: 34512318

Early Prediction of Tacrolimus-Induced Tubular Toxicity in Pediatric Refractory Nephrotic Syndrome Using Machine Learning

Overview
Journal Front Pharmacol
Date 2021 Sep 13
PMID 34512318
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Tacrolimus(TAC)-induced nephrotoxicity, which has a large individual variation, may lead to treatment failure or even the end-stage renal disease. However, there is still a lack of effective models for the early prediction of TAC-induced nephrotoxicity, especially in nephrotic syndrome(NS). We aimed to develop and validate a predictive model of TAC-induced tubular toxicity in children with NS using machine learning based on comprehensive clinical and genetic variables. A retrospective cohort of 218 children with NS admitted between June 2013 and December 2018 was used to establish the models, and 11 children were prospectively enrolled for external validation. We screened 47 clinical features and 244 genetic variables. The changes in urine N- acetyl- β-D- glucosaminidase(NAG) levels before and after administration was used as an indicator of renal tubular toxicity. Five machine learning algorithms, including extreme gradient boosting (XGBoost), gradient boosting decision tree (GBDT), extremely random trees (ET), random forest (RF), and logistic regression (LR) were used for model generation and validation. Four genetic variables, including rs3824934_GG, HSD11B1 rs846910_AG, MAP2K6 rs17823202_GG, and SCARB2 rs6823680_CC were incorporated into the final model. The XGBoost model has the best performance: sensitivity 75%, specificity 77.8%, accuracy 77.3%, and AUC 78.9%. A pre-administration model with good performance for predicting TAC-induced nephrotoxicity in NS was developed and validated using machine learning based on genetic factors. Physicians can estimate the possibility of nephrotoxicity in NS patients using this simple and accurate model to optimize treatment regimen before administration or to intervene in time after administration to avoid kidney damage.

Citing Articles

Risk Prediction of Liver Injury in Pediatric Tuberculosis Treatment: Development of an Automated Machine Learning Model.

Zeng Y, Lu H, Li S, Shi Q, Liu L, Gong Y Drug Des Devel Ther. 2025; 19():239-250.

PMID: 39830784 PMC: 11740905. DOI: 10.2147/DDDT.S495555.


Rituximab versus tacrolimus as corticosteroid-sparing therapy for children with steroid-dependent nephrotic syndrome: A systematic review and meta-analysis of randomized and nonrandomized controlled trials.

Ang J, Widjanarko N, Ekaputra A Tzu Chi Med J. 2024; 36(3):319-329.

PMID: 38993828 PMC: 11236076. DOI: 10.4103/tcmj.tcmj_234_23.


Optimizing the initial tacrolimus dosage in Chinese children with lung transplantation within normal hematocrit levels.

Hu K, He S, Zhang C, Zhang Y, Gu Q, Shi H Front Pediatr. 2024; 12:1090455.

PMID: 38357508 PMC: 10864595. DOI: 10.3389/fped.2024.1090455.


Physiologically based pharmacokinetic model combined with reverse dose method to study the nephrotoxic tolerance dose of tacrolimus.

Cai L, Ke M, Wang H, Wu W, Lin R, Huang P Arch Toxicol. 2023; 97(10):2659-2673.

PMID: 37572130 DOI: 10.1007/s00204-023-03576-3.


Comparison and development of machine learning for thalidomide-induced peripheral neuropathy prediction of refractory Crohn's disease in Chinese population.

Mao J, Chao K, Jiang F, Ye X, Yang T, Li P World J Gastroenterol. 2023; 29(24):3855-3870.

PMID: 37426324 PMC: 10324537. DOI: 10.3748/wjg.v29.i24.3855.

References
1.
Kruppa J, Ziegler A, Konig I . Risk estimation and risk prediction using machine-learning methods. Hum Genet. 2012; 131(10):1639-54. PMC: 3432206. DOI: 10.1007/s00439-012-1194-y. View

2.
Marchewka Z, Kuzniar J, Zynek-Litwin M, Falkiewicz K, Szymanska B, Roszkowska A . Kidney graft function in long-term cyclosporine and tacrolimus treatment: comparative study with nephrotoxicity markers. Transplant Proc. 2009; 41(5):1660-5. DOI: 10.1016/j.transproceed.2009.01.116. View

3.
Kuang X, Huang W, Xu H, Shi Y, Zhang X, Niu X . 254C>G: a TRPC6 promoter variation associated with enhanced transcription and steroid-resistant nephrotic syndrome in Chinese children. Pediatr Res. 2013; 74(5):511-6. DOI: 10.1038/pr.2013.144. View

4.
Jahan A, Prabha R, Chaturvedi S, Mathew B, Fleming D, Agarwal I . Clinical efficacy and pharmacokinetics of tacrolimus in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2015; 30(11):1961-7. DOI: 10.1007/s00467-015-3133-3. View

5.
Athreya A, Neavin D, Carrillo-Roa T, Skime M, Biernacka J, Frye M . Pharmacogenomics-Driven Prediction of Antidepressant Treatment Outcomes: A Machine-Learning Approach With Multi-trial Replication. Clin Pharmacol Ther. 2019; 106(4):855-865. PMC: 6739122. DOI: 10.1002/cpt.1482. View